Riyad Al‐Lehebi

814 total citations
14 papers, 61 citations indexed

About

Riyad Al‐Lehebi is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Riyad Al‐Lehebi has authored 14 papers receiving a total of 61 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 9 papers in Pulmonary and Respiratory Medicine and 1 paper in Surgery. Recurrent topics in Riyad Al‐Lehebi's work include Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Riyad Al‐Lehebi is often cited by papers focused on Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Riyad Al‐Lehebi collaborates with scholars based in Saudi Arabia, United Kingdom and Colombia. Riyad Al‐Lehebi's co-authors include Hani Almoallim, Siraj Wali, Maarten Beekman, Hamdan Al‐Jahdali, Michael E. Wechsler, Lakmini Bulathsinhala, David Price, Mohamed Al-Moamary, Victoria Carter and Mark Hew and has published in prestigious journals such as CHEST Journal, The Lancet Respiratory Medicine and Clinical Rheumatology.

In The Last Decade

Riyad Al‐Lehebi

12 papers receiving 61 citations

Peers

Countries citing papers authored by Riyad Al‐Lehebi

Since Specialization

Citations

This map shows the geographic impact of Riyad Al‐Lehebi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riyad Al‐Lehebi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riyad Al‐Lehebi more than expected).

Fields of papers citing papers by Riyad Al‐Lehebi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riyad Al‐Lehebi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riyad Al‐Lehebi. The network helps show where Riyad Al‐Lehebi may publish in the future.

Co-authorship network of co-authors of Riyad Al‐Lehebi

This figure shows the co-authorship network connecting the top 25 collaborators of Riyad Al‐Lehebi. A scholar is included among the top collaborators of Riyad Al‐Lehebi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riyad Al‐Lehebi. Riyad Al‐Lehebi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Higher adherence to biologic therapies in asthma is associated with improved clinical outcomes: Retrospective analysis of claims data 2025 ·Njira Lugogo, Brian D. Modena, (unknown), Jiaxuan Wang, Peter A. Howarth, Riyad Al‐Lehebi, (unknown), (unknown), Jeremiah Hwee, Gerald E. Smith, (unknown), Arijita Deb, (unknown)	0
2	Regional challenges to optimize the management of patients with severe asthma type 2 inflammation: a Delphi consensus in seven countries 2025 ·Journal of Asthma ·Liam G. Heaney, Désirée Larenas‐Linnemann, Riyad Al‐Lehebi, Rodrigo Abensur Athanazio, (unknown), (unknown), (unknown), Anahí Yáñez, (unknown), Márcia Margaret Menezes Pizzichini, Deepak Talwar, Emílio Pizzichini, Gur Levy, María Laucho-Contreras	1
3	The Impact of Biological Therapies and the Significance of Their Adherence on Asthma Outcomes in a Single Tertiary Asthma Center 2025 ·Journal of Asthma and Allergy ·Riyad Al‐Lehebi, (unknown), (unknown)	1
4	Real-World Effectiveness of Mepolizumab in Severe Asthma: Results from the Multi-country, Self-controlled Nucala Effectiveness Study (NEST) 2024 ·Advances in Therapy ·Riyad Al‐Lehebi, Mona Al‐Ahmad, Venkata Nagarjuna Maturu, (unknown), Bassam Mahboub, (unknown), Patricia Fernández, Cláudia Soares, Gabriela de Azevedo Abreu, (unknown), (unknown), Alejandro Raimondi, María Laucho-Contreras, (unknown), Gur Levy, Sevim Bavbek	6
5	The Saudi Thoracic Society Evidence-based guidelines for the diagnosis and management of chronic obstructive pulmonary disease 2024 ·Annals of Thoracic Medicine ·(unknown), Riyad Al‐Lehebi, Hani Lababidi, Faris Alhejaili, (unknown), (unknown), Majdy Idrees, (unknown), Abdullah Al-Shimemeri, Mohammed Al Ghobain, Ali Alaraj, Esam H. Alhamad	0
6	The Saudi initiative for asthma – 2024 update: Guidelines for the diagnosis and management of asthma in adults and children 2023 ·Annals of Thoracic Medicine ·Mohamed Al-Moamary, (unknown), Riyad Al‐Lehebi, Majdy Idrees, (unknown), (unknown), (unknown), (unknown), Abdullah A. Yousef, (unknown), Mohamed S. Al‐Hajjaj	6
7	Baseline Characteristics of Patients With Severe Asthma Treated With Mepolizumab: An Interim Analysis of a Multi-country Real-world Cohort 2023 ·Riyad Al‐Lehebi, Venkata Nagarjuna Maturu, Bassam Mahboub, Sevim Bavbek, (unknown), (unknown), Cláudia Soares, Gabriela de Azevedo Abreu, (unknown), (unknown), (unknown), (unknown), (unknown), Emílio Pizzichini, (unknown), (unknown)	1
8	Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study 2022 ·BMC Pulmonary Medicine ·Hamdan Al‐Jahdali, Siraj Wali, Amr S. Albanna, Riyad Al‐Lehebi, (unknown), (unknown), Maarten Beekman	8
9	When single-inhaler triple therapy is a preferred option in asthma management? 2022 ·Annals of Thoracic Medicine ·MohamedS Al-Moamary, Riyad Al‐Lehebi, (unknown), (unknown)	2
10	Overprescription of short‐acting β₂‐agonists among patients with asthma in Saudi Arabia: Results from the SABINA III cohort study 2022 ·The Clinical Respiratory Journal ·Hamdan Al‐Jahdali, Siraj Wali, (unknown), (unknown), Riyad Al‐Lehebi, (unknown), (unknown), (unknown), (unknown), Maarten Beekman	4
11	Asthma Phenotyping in Primary Care: Applying the International Severe Asthma Registry Eosinophil Phenotype Algorithm Across All Asthma Severities 2021 ·The Journal of Allergy and Clinical Immunology In Practice ·Marjan Kerkhof, Trung N. Tran, Riyad Al‐Lehebi, Giorgio Walter Canonica, Liam G. Heaney, Mark Hew, Luis Pérez de Llano, Michael E. Wechsler, Lakmini Bulathsinhala, Victoria Carter, Isha Chaudhry, Neva Eleangovan, Ruth Murray, Chris Price, David Price	12
12	AROMATHERAPY MAY NOT BE SO RELAXING AFTER ALL: A CASE OF ACUTE EOSINOPHILIC PNEUMONIA 2021 ·CHEST Journal ·Riyad Al‐Lehebi, (unknown), (unknown)	2
13	Respiratory disease and Ramadan 2020 ·The Lancet Respiratory Medicine ·(unknown), Riyad Al‐Lehebi	3
14	Delayed diagnosis of systemic lupus erythematosus due to lack of competency skills in musculoskeletal examination 2006 ·Clinical Rheumatology ·Hani Almoallim, (unknown), Riyad Al‐Lehebi, (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact